Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Welsh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2009
Single-channel analysis of ethanol enhancement of glycine receptor functionBrian T Welsh, Beth E Goldstein, S John Mihic
Alcoholism, Clinical and Experimental Research|July 1, 2010
Ethanol enhances taurine-activated glycine receptor functionBrian T Welsh, Dean Kirson, Hunter M Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Disruption of an intersubunit electrostatic bond is a critical step in glycine receptor activationJelena Todorovic, Brian T Welsh, Edward J Bertaccini, et al.
Regulatory Toxicology and Pharmacology : RTP|June 4, 2023
Genotoxicity evaluation of cannabidiolRayetta G Henderson, Brian T Welsh, Kristen R Trexler, et al.
International Journal of Toxicology|July 13, 2021
Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying DiseaseBrian T Welsh, Shaun M Cote, Deborah Meshulam, et al.
Brain Research|December 8, 2016
Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptorBrian T Welsh, Jelena Todorovic, Dean Kirson, et al.
Annual Review of Food Science and Technology|January 7, 2016
Caffeine: Friend or Foe?Candace Doepker, Harris R Lieberman, Andrew Paul Smith, et al.
International Journal of Toxicology|March 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid TumorsBrian T Welsh, Ryan Faucette, Sanela Bilic, et al.
Archives of Neurology|June 13, 2012
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotypeJohn M Ringman, David Elashoff, Daniel H Geschwind, et al.
International Journal of Toxicology|November 11, 2024
Enhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of FelzartamabDoris Mangelberger-Eberl, Mary Ellen Cosenza, Stefan Härtle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2009
Single-channel analysis of ethanol enhancement of glycine receptor functionBrian T Welsh, Beth E Goldstein, S John Mihic
Alcoholism, Clinical and Experimental Research|July 1, 2010
Ethanol enhances taurine-activated glycine receptor functionBrian T Welsh, Dean Kirson, Hunter M Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Disruption of an intersubunit electrostatic bond is a critical step in glycine receptor activationJelena Todorovic, Brian T Welsh, Edward J Bertaccini, et al.
Regulatory Toxicology and Pharmacology : RTP|June 4, 2023
Genotoxicity evaluation of cannabidiolRayetta G Henderson, Brian T Welsh, Kristen R Trexler, et al.
International Journal of Toxicology|July 13, 2021
Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying DiseaseBrian T Welsh, Shaun M Cote, Deborah Meshulam, et al.
Brain Research|December 8, 2016
Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptorBrian T Welsh, Jelena Todorovic, Dean Kirson, et al.
Annual Review of Food Science and Technology|January 7, 2016
Caffeine: Friend or Foe?Candace Doepker, Harris R Lieberman, Andrew Paul Smith, et al.
International Journal of Toxicology|March 19, 2021
Nonclinical Development of SRK-181: An Anti-Latent TGFβ1 Monoclonal Antibody for the Treatment of Locally Advanced or Metastatic Solid TumorsBrian T Welsh, Ryan Faucette, Sanela Bilic, et al.
Archives of Neurology|June 13, 2012
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotypeJohn M Ringman, David Elashoff, Daniel H Geschwind, et al.
International Journal of Toxicology|November 11, 2024
Enhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of FelzartamabDoris Mangelberger-Eberl, Mary Ellen Cosenza, Stefan Härtle, et al.
Pageof 2